Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease.
Eng
C
C
Division of Cancer Epidemiology and Control, Dana-Farber Cancer Institute, Boston, MA 02115-6084, USA.
D005820:Genetic Testing; D006627:Hirschsprung Disease / Q000235:genetics*; D006801:Humans; D018761:Multiple Endocrine Neoplasia Type 1 / Q000235:genetics; D018813:Multiple Endocrine Neoplasia Type 2a / Q000175:diagnosis / Q000235:genetics*; D018814:Multiple Endocrine Neoplasia Type 2b / Q000175:diagnosis / Q000235:genetics*; D009154:Mutation; D010673:Pheochromocytoma / Q000235:genetics; D000090063:Proto-Oncogene Mas; D011519:Proto-Oncogenes / Q000235:genetics*; D013964:Thyroid Neoplasms / Q000235:genetics